These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35371954)

  • 41. Sonographic Features of Small (< 4 cm) Renal Tumors With Low Signal Intensity on T2-Weighted MR Images: Differentiating Minimal-Fat Angiomyolipoma From Renal Cell Carcinoma.
    Park KJ; Kim MH; Kim JK; Cho KS
    AJR Am J Roentgenol; 2018 Sep; 211(3):605-613. PubMed ID: 30040467
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differentiation of Clear Cell Renal Cell Carcinoma from other Renal Cell Carcinoma Subtypes and Benign Oncocytoma Using Quantitative MDCT Enhancement Parameters.
    Moldovanu CG; Petresc B; Lebovici A; Tamas-Szora A; Suciu M; Crisan N; Medan P; Buruian MM
    Medicina (Kaunas); 2020 Oct; 56(11):. PubMed ID: 33126571
    [No Abstract]   [Full Text] [Related]  

  • 43. Validation of aorta-lesion-attenuation difference on preoperative contrast-enhanced computed tomography scan to differentiate between malignant and benign oncocytic renal tumors.
    Grajo JR; Batra NV; Bozorgmehri S; Magnelli LL; Pavlinec J; O'Malley P; Su LM; Crispen PL
    Abdom Radiol (NY); 2021 Jul; 46(7):3269-3279. PubMed ID: 33665734
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Utility of material-specific fat images derived from rapid-kVp-switch dual-energy renal mass CT for diagnosis of renal angiomyolipoma.
    Walker D; Udare A; Chatelain R; McInnes M; Flood T; Schieda N
    Acta Radiol; 2021 Sep; 62(9):1263-1272. PubMed ID: 32957794
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Can whole-tumor radiomics-based CT analysis better differentiate fat-poor angiomyolipoma from clear cell renal cell caricinoma: compared with conventional CT analysis?
    Ma Y; Cao F; Xu X; Ma W
    Abdom Radiol (NY); 2020 Aug; 45(8):2500-2507. PubMed ID: 31980867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative evaluation of contrast-enhanced ultrasound for differentiation of renal cell carcinoma subtypes and angiomyolipoma.
    Li CX; Lu Q; Huang BJ; Xue LY; Yan LX; Zheng FY; Wen JX; Wang WP
    Eur J Radiol; 2016 Apr; 85(4):795-802. PubMed ID: 26971426
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nomogram predictive model for differentiation between renal oncocytoma and chromophobe renal cell carcinoma at multi-phasic CT: a retrospective study.
    Elsayed Sharaf D; Shebel H; El-Diasty T; Osman Y; Khater SM; Abdelhamid M; Abou El Atta HM
    Clin Radiol; 2022 Oct; 77(10):767-775. PubMed ID: 35764438
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exploring Multiphoton Microscopy as a Novel Tool to Differentiate Chromophobe Renal Cell Carcinoma From Oncocytoma in Fixed Tissue Sections.
    Jain M; Robinson BD; Wu B; Khani F; Mukherjee S
    Arch Pathol Lab Med; 2018 Mar; 142(3):383-390. PubMed ID: 29219617
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnosis of renal angiomyolipoma with hounsfield unit thresholds: effect of size of region of interest and nephrographic phase imaging.
    Davenport MS; Neville AM; Ellis JH; Cohan RH; Chaudhry HS; Leder RA
    Radiology; 2011 Jul; 260(1):158-65. PubMed ID: 21555349
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of CT, MRI imaging features of renal cell carcinoma with different histopathological types.
    Wang X; Kong W; Wang Y; Wang Y; Chen Y; Shi Z; Liu Y
    J BUON; 2021; 26(5):2053-2058. PubMed ID: 34761616
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A triple-classification for differentiating renal oncocytoma from renal cell carcinoma subtypes and CK7 expression evaluation: a radiomics analysis.
    Yu Z; Ding J; Pang H; Fang H; He F; Xu C; Li X; Ren K
    BMC Urol; 2022 Sep; 22(1):147. PubMed ID: 36096829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aorta-Lesion-Attenuation-Difference (ALAD) on contrast-enhanced CT: a potential imaging biomarker for differentiating malignant from benign oncocytic neoplasms.
    Dhyani M; Grajo JR; Rodriguez D; Chen Z; Feldman A; Tambouret R; Gervais DA; Arellano RS; Hahn PF; Samir AE
    Abdom Radiol (NY); 2017 Jun; 42(6):1734-1743. PubMed ID: 28197683
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MRI features of renal oncocytoma and chromophobe renal cell carcinoma.
    Rosenkrantz AB; Hindman N; Fitzgerald EF; Niver BE; Melamed J; Babb JS
    AJR Am J Roentgenol; 2010 Dec; 195(6):W421-7. PubMed ID: 21098174
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
    Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
    AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Utility of the Aortic-Lesion-Attenuation-Difference (ALAD) and Peak Early-Phase Enhancement Ratio (PEER) to differentiate benign from malignant renal masses.
    Kahn AE; Lomax SJ; Bajalia EM; Ball CT; Thiel DD
    Can J Urol; 2020 Aug; 27(4):10278-10284. PubMed ID: 32861252
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HNF-1β as an immunohistochemical marker for distinguishing chromophobe renal cell carcinoma and hybrid oncocytic tumors from renal oncocytoma.
    An J; Park CK; Kim M; Joo JW; Cho NH
    Virchows Arch; 2021 Mar; 478(3):459-470. PubMed ID: 32816058
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Segmental enhancement inversion at biphasic multidetector CT: characteristic finding of small renal oncocytoma.
    Kim JI; Cho JY; Moon KC; Lee HJ; Kim SH
    Radiology; 2009 Aug; 252(2):441-8. PubMed ID: 19508984
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Angiomyolipoma with minimal fat: differentiation from clear cell renal cell carcinoma and papillary renal cell carcinoma by texture analysis on CT images.
    Yan L; Liu Z; Wang G; Huang Y; Liu Y; Yu Y; Liang C
    Acad Radiol; 2015 Sep; 22(9):1115-21. PubMed ID: 26031228
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Contrast-Enhanced CT Texture Analysis for Distinguishing Fat-Poor Renal Angiomyolipoma From Chromophobe Renal Cell Carcinoma.
    Yang G; Gong A; Nie P; Yan L; Miao W; Zhao Y; Wu J; Cui J; Jia Y; Wang Z
    Mol Imaging; 2019; 18():1536012119883161. PubMed ID: 31625454
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lipid-poor renal angiomyolipoma: Differentiation from clear cell renal cell carcinoma using wash-in and washout characteristics on contrast-enhanced computed tomography.
    Xie P; Yang Z; Yuan Z
    Oncol Lett; 2016 Mar; 11(3):2327-2331. PubMed ID: 26998171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.